Skip to main content
SpringerLink
Log in

TNF-α inhibitors increase risk of HBV reactivation if HBsAg-positive

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Wang X, et al. Risk for Hepatitis B Virus Reactivation in Patients with Psoriasis Treated with Biological Agents: A Systematic Review and Meta-Analysis Dermatology and Therapy : 29 Jan 2022. Available from: URL: https://doi.org/10.1007/s13555-022-00682-5

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

TNF-α inhibitors increase risk of HBV reactivation if HBsAg-positive. Reactions Weekly 1892, 10 (2022). https://doi.org/10.1007/s40278-022-09552-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-09552-1

Search

Navigation